Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |